Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
102.20    -1.00 (-0.97%)
Bid:
101.40
Ask:
102.80
Spread: 1.40 (1.381%)
Market Cap: £167.55m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Board changes

30 Nov 2022 07:00

RNS Number : 9965H
Synthomer PLC
30 November 2022
 

 

30th November 2022

 

Synthomer plc

 

Board changes

 

Synthomer plc ('Synthomer' or 'the Company') announces that it has appointed Anant Prakash as Chief Counsel and Company Secretary. Anant will join Synthomer on 1st December 2022, succeeding Richard Atkinson who will retire at the end of February 2023 following a handover period. 

 

Anant has spent the last five years at Ultra Electronics Group, latterly as General Counsel, Europe and Asia Pacific. Before joining Ultra, Anant worked at the international law firm Slaughter and May, and has experience in M&A, JVs, private equity, compliance, corporate governance and global investigations. He holds an undergraduate degree in History, a graduate Diploma in Law and a Postgraduate Diploma in Legal Practice. 

 

Cynthia Dubin has resigned as Non-Executive Director and Chair of Audit Committee as of 29 November 2022. Ian Tyler, who joined the Board as a Non-Executive Director in June 2022 as a very experienced NED and following a distinguished executive career, will succeed Cynthia as Chair of Audit Committee. 

 

Brendan Connolly, Senior Independent Director, will retire from the Board in April 2023 after nine years' service. At that point, Ian Tyler will also succeed him as Senior Independent Director. Holly Van Deursen, who has been a Non-Executive Director and member of the Remuneration Committee since September 2018, will succeed Brendan as Chair of the Remuneration Committee. 

 

 

Caroline Johnstone, Chair of Synthomer, said:

 

"I am delighted to welcome Anant to Synthomer and we look forward to working with him to further evolve and deliver our priorities as a Board.

 

I wish Richard a long and happy retirement. Over his 24 years with Synthomer he has made a very significant contribution to the successful development of the Synthomer Group.

 

I want to thank Cynthia for her contribution to the Board and committees on which she served. Her executive and banking experience has been highly valued. 

 

We are very fortunate to have two experienced Non-Executives in Ian and Holly and I look forward to working with them both in their new roles."

 

 

For enquiries contact:

Investors: Tim Hughes, Synthomer + 44 7764 859147

 

Press: Charlie Armitstead, Teneo +44 7703 330269

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABIBDBISDDGDC
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.